Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage dna pk'

Search results for: 'research area dna damage dna pk'

Items 1-10 of 62

Page
per page
  1. NU7441 (KU-57788)
    A8315 NU7441 (KU-57788)
     4 Citation
    Target: PI3K|DNA-PK
    Summary: DNA-PK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.13 mg/mL
  2. NU 7026
    A8649 NU 7026
    Target: PI3K|DNA-PK|ATM
    Summary: DNPK inhibitor,ATP-competitive and potent
      insoluble in EtOH; insoluble in DMSO; insoluble in H2O
  3. Daun02
    A3352 Daun02
     2 Citation
    Summary: Cell viability inhibitor,DNA synthisis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.92 mg/mL
  4. Gemcitabine HCl
    A1402 Gemcitabine HCl
    Summary: Inhibits DNA synthesis,deoxycytidine analog
      ≥10.1 mg/mL
  5. Cytarabine
    A8405 Cytarabine
     1 Citation
    Summary: cytotoxic agent, blocks DNA synthesis
      insoluble in EtOH; ≥28.6 mg/mL
  6. Carboplatin
    A2171 Carboplatin
    Summary: Antitumor agent that forms platinum-DNA adducts.
      insoluble in ETOH; ≥9.28 mg/mL
  7. Fludarabine Phosphate (Fludara)
    A8317 Fludarabine Phosphate (Fludara)
     2 Citation
    Target: STAT
    Summary: Inhibits STAT1 activation and DNA synthesis
      insoluble in EtOH; ≥17.6 mg/mL
  8. Oxaliplatin
    A8648 Oxaliplatin
     3 Citation
    Summary: Antitumor agent
      insoluble in EtOH; ≥37.25 mg/mL
  9. Mitomycin C
    A4452 Mitomycin C
     3 Citation
    Summary: Inhibits DNA synthesis,antibiotic and antitumor agent
      insoluble in H2O; insoluble in EtOH; ≥16.7 mg/mL
  10. Fludarabine
    A5424 Fludarabine
    Summary: DNA synthsis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL

Items 1-10 of 62

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 59item
  2. Natural Products 2item
  3. Lab Reagents 1 item
Specificity
  1. Selective 41item
Reversibility
  1. Reversible 2item
Target
  1. Akt 1 item
  2. PI3K 6item
  3. mTOR 4item
  4. AP-1 1 item
  5. Chk 2item
  6. Thymidylate Synthase 1 item
  7. STAT 4item
  8. Estrogen and Related Receptors 1 item
  9. Reverse Transcriptases 1 item
  10. JAK 1 item
  11. DNA-PK 6item
  12. Topoisomerases 9item
  13. DNA Methyltransferases 2item
  14. Ubiquitin-specific proteases 1 item
  15. Fatty-acid-binding proteins (FABPs) 1 item
  16. ATM/ATR 2item
  17. HIV Integrases 1 item
  18. BLM 1 item
  19. HSV 1 item
  20. Synthases/Synthetases 2item
  21. MAGL 1 item
  22. Histamine H1 Receptors 1 item
  23. RNA Polymerases 2item
  24. CMV 1 item
  25. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  26. Cytidine deaminases 1 item
  27. PPAR 1 item
  28. PTK 1 item
  29. prolactin secretion 1 item
  30. gonadotropin release 1 item
  31. benzodiazepine receptor 1 item
  32. TRPC channel 1 item
  33. ATM 1 item
  34. Sirtuin 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 1 item
  3. Acute Renal Failure 1 item
  4. Bladder Cancer 1 item
  5. Bladder Carcinoma 1 item
  6. Bladder Diseases 1 item
  7. Breast Cancer 9item
  8. Cancer 43item
  9. Cervical Cancer 2item
  10. Colon Cancer 7item
  11. Colorectal Cancer 4item
  12. Glioblastoma 3item
  13. Glioma 1 item
  14. Hepatocellular Carcinoma 2item
  15. HIV 1 item
  16. HIV Infections 1 item
  17. Inflammatory Diseases 1 item
  18. Leukemia 5item
  19. Lung Cancer 3item
  20. Lymphoma 3item
  21. Melanoma 4item
  22. Multiple Myeloma 1 item
  23. Myeloma 2item
  24. Neuroblastoma 1 item
  25. Non-small Cell Lung Carcinoma 1 item
  26. Ovarian Cancer 6item
  27. Pancreatic Cancer 2item
  28. Prostate Cancer 5item
  29. Sarcoma 1 item
  30. Squamous Cell Carcinoma 1 item
  31. Testicular Cancer 2item
  32. Type 2 Diabetes 1 item